-
1
-
-
77950513204
-
Early recognition and prevention of chronic kidney disease
-
James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010;375:1296-1309.
-
(2010)
Lancet
, vol.375
, pp. 1296-1309
-
-
James, M.T.1
Hemmelgarn, B.R.2
Tonelli, M.3
-
2
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
4
-
-
0034079643
-
Cardiovascular disease and chronic renal disease: A new paradigm
-
Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(4 Suppl. 1):S117-S131.
-
(2000)
Am J Kidney Dis
, vol.35
, Issue.4 SUPPL. 1
-
-
Sarnak, M.J.1
Levey, A.S.2
-
5
-
-
59449108700
-
KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004
-
Snyder JJ, Collins AJ. KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004. Am J Nephrol 2009;30: 44-54.
-
(2009)
Am J Nephrol
, vol.30
, pp. 44-54
-
-
Snyder, J.J.1
Collins, A.J.2
-
6
-
-
1642540483
-
Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition
-
Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004;291:451-459.
-
(2004)
JAMA
, vol.291
, pp. 451-459
-
-
Liu, Y.1
Coresh, J.2
Eustace, J.A.3
Longenecker, J.C.4
Jaar, B.5
Fink, N.E.6
Tracy, R.P.7
Powe, N.R.8
Klag, M.J.9
-
7
-
-
0031733696
-
Clinical epidemiology of cardiovascular disease in chronic renal disease
-
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl. 3):S112-S119.
-
(1998)
Am J Kidney Dis
, vol.32
, Issue.5 SUPPL. 3
-
-
Foley, R.N.1
Parfrey, P.S.2
Sarnak, M.J.3
-
8
-
-
79959746706
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial
-
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C,Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377:2181-2192.
-
(2011)
Lancet
, vol.377
, pp. 2181-2192
-
-
Baigent, C.1
Landray, M.J.2
Reith, C.3
Emberson, J.4
Wheeler, D.C.5
Tomson Cwanner, C.6
Krane, V.7
Cass, A.8
Craig, J.9
Neal, B.10
Jiang, L.11
Hooi, L.S.12
Levin, A.13
Agodoa, L.14
Gaziano, M.15
Kasiske, B.16
Walker, R.17
Massy, Z.A.18
Feldt-Rasmussen, B.19
Krairittichai, U.20
Ophascharoensuk, V.21
Fellstrom, B.22
Holdaas, H.23
Tesar, V.24
Wiecek, A.25
Grobbee, D.26
De Zeeuw, D.27
Gronhagen-Riska, C.28
Dasgupta, T.29
Lewis, D.30
Herrington, W.31
Mafham, M.32
Majoni, W.33
Wallendszus, K.34
Grimm, R.35
Pedersen, T.36
Tobert, J.37
Armitage, J.38
Baxter, A.39
Bray, C.40
Chen, Y.41
Chen, Z.42
Hill, M.43
Knott, C.44
Parish, S.45
Simpson, D.46
Sleight, P.47
Young, A.48
Collins, R.49
more..
-
9
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Gronhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Suleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wuthrich RP, Gottlow M, Johnsson E, Zannad F. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395-1407.
-
(2009)
N Engl J Med
, vol.360
, pp. 1395-1407
-
-
Fellstrom, B.C.1
Jardine, A.G.2
Schmieder, R.E.3
Holdaas, H.4
Bannister, K.5
Beutler, J.6
Chae, D.W.7
Chevaile, A.8
Cobbe, S.M.9
Gronhagen-Riska, C.10
De Lima, J.J.11
Lins, R.12
Mayer, G.13
McMahon, A.W.14
Parving, H.H.15
Remuzzi, G.16
Samuelsson, O.17
Sonkodi, S.18
Sci, D.19
Suleymanlar, G.20
Tsakiris, D.21
Tesar, V.22
Todorov, V.23
Wiecek, A.24
Wuthrich, R.P.25
Gottlow, M.26
Johnsson, E.27
Zannad, F.28
more..
-
10
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-248.
-
(2005)
N Engl J Med
, vol.353
, pp. 238-248
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
Olschewski, M.4
Mann, J.F.5
Ruf, G.6
Ritz, E.7
-
11
-
-
84865628946
-
Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-analysis
-
Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012;157:263-275.
-
(2012)
Ann Intern Med
, vol.157
, pp. 263-275
-
-
Palmer, S.C.1
Craig, J.C.2
Navaneethan, S.D.3
Tonelli, M.4
Pellegrini, F.5
Strippoli, G.F.6
-
12
-
-
84865658424
-
Lipid-lowering therapy in persons with chronic kidney disease: A systematic review and meta-analysis
-
Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012;157:251-262.
-
(2012)
Ann Intern Med
, vol.157
, pp. 251-262
-
-
Upadhyay, A.1
Earley, A.2
Lamont, J.L.3
Haynes, S.4
Wanner, C.5
Balk, E.M.6
-
13
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
-
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
-
(1996)
Control Clin Trials
, vol.17
, pp. 1-12
-
-
Jadad, A.R.1
Moore, R.A.2
Carroll, D.3
Jenkinson, C.4
Reynolds, D.J.5
Gavaghan, D.J.6
McQuay, H.J.7
-
15
-
-
67650082354
-
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
-
Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
-
(2009)
BMJ
, vol.338
-
-
Law, M.R.1
Morris, J.K.2
Wald, N.J.3
-
16
-
-
79959720383
-
Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis
-
Han SH, Kang EW, Yoon SJ, Yoon HS, Lee HC, Yoo TH, Choi KH, Han DS, Kang SW. Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2011;26:3722-3728.
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 3722-3728
-
-
Han, S.H.1
Kang, E.W.2
Yoon, S.J.3
Yoon, H.S.4
Lee, H.C.5
Yoo, T.H.6
Choi, K.H.7
Han, D.S.8
Kang, S.W.9
-
17
-
-
38049041900
-
Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients
-
Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Pharmacother 2008;42:9-15.
-
(2008)
Ann Pharmacother
, vol.42
, pp. 9-15
-
-
Joy, M.S.1
Dornbrook-Lavender, K.A.2
Chin, H.3
Hogan, S.L.4
Denu-Ciocca, C.5
-
18
-
-
14544292416
-
Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis
-
Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis. Pharmacotherapy 2005;25:335-344.
-
(2005)
Pharmacotherapy
, vol.25
, pp. 335-344
-
-
Dornbrook-Lavender, K.A.1
Joy, M.S.2
Denu-Ciocca, C.J.3
Chin, H.4
Hogan, S.L.5
Pieper, J.A.6
-
19
-
-
8144224441
-
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
-
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004;110:2809-2816.
-
(2004)
Circulation
, vol.110
, pp. 2809-2816
-
-
Asselbergs, F.W.1
Diercks, G.F.2
Hillege, H.L.3
Van Boven, A.J.4
Janssen, W.M.5
Voors, A.A.6
De Zeeuw, D.7
De Jong, P.E.8
Van Veldhuisen, D.J.9
Van Gilst, W.H.10
-
20
-
-
33847248452
-
Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency
-
Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency. Am J Kidney Dis 2007;49:373-382.
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 373-382
-
-
Chonchol, M.1
Cook, T.2
Kjekshus, J.3
Pedersen, T.R.4
Lindenfeld, J.5
-
21
-
-
70350121639
-
Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: An analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)
-
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). Am J Kidney Dis 2009;54: 810-819.
-
(2009)
Am J Kidney Dis
, vol.54
, pp. 810-819
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.5
Livingstone, S.J.6
Charlton-Menys, V.7
Demicco, D.A.8
Fuller, J.H.9
-
22
-
-
0037840242
-
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial
-
Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016.
-
(2003)
Lancet
, vol.361
, pp. 2005-2016
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
Sleigh, P.4
Peto, R.5
-
23
-
-
71849095929
-
Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: A post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study
-
Kendrick J, Shlipak MG, Targher G, Cook T, Lindenfeld J, Chonchol M. Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study. Am J Kidney Dis 2010;55:42-49.
-
(2010)
Am J Kidney Dis
, vol.55
, pp. 42-49
-
-
Kendrick, J.1
Shlipak, M.G.2
Targher, G.3
Cook, T.4
Lindenfeld, J.5
Chonchol, M.6
-
24
-
-
13844255370
-
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy
-
Lemos PA, Serruys PW, de Feyter P, Mercado NF, Goedhart D, Saia F, Arampatzis CA, Soares PR, Ciccone M, Arquati M, Cortellaro M, Rutsch W, Legrand V. Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy). Am J Cardiol 2005;95:445-451.
-
(2005)
Am J Cardiol
, vol.95
, pp. 445-451
-
-
Lemos, P.A.1
Serruys, P.W.2
De Feyter, P.3
Mercado, N.F.4
Goedhart, D.5
Saia, F.6
Arampatzis, C.A.7
Soares, P.R.8
Ciccone, M.9
Arquati, M.10
Cortellaro, M.11
Rutsch, W.12
Legrand, V.13
-
25
-
-
70349510736
-
Pravastatin and cardiovascular risk in moderate chronic kidney disease
-
Nakamura H, Mizuno K, Ohashi Y, Yoshida T, Hirao K, Uchida Y. Pravastatin and cardiovascular risk in moderate chronic kidney disease. Atherosclerosis 2009;206: 512-517.
-
(2009)
Atherosclerosis
, vol.206
, pp. 512-517
-
-
Nakamura, H.1
Mizuno, K.2
Ohashi, Y.3
Yoshida, T.4
Hirao, K.5
Uchida, Y.6
-
26
-
-
77949332406
-
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated highsensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial
-
Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated highsensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 2010;55:1266-1273.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1266-1273
-
-
Ridker, P.M.1
MacFadyen, J.2
Cressman, M.3
Glynn, R.J.4
-
27
-
-
28444438873
-
Low-dose atorvastatin in severe chronic kidney disease patients: A randomized, controlled endpoint study
-
Stegmayr BG, Brannstrom M, Bucht S, Crougneau V, Dimeny E, Ekspong A, Eriksson M, Granroth B, Grontoft KC, Hadimeri H, Holmberg B, Ingman B, Isaksson B, Johansson G, Lindberger K, Lundberg L, Mikaelsson L, Olausson E, Persson B, Stenlund H, Wikdahl AM. Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study. Scand J Urol Nephrol 2005;39:489-497.
-
(2005)
Scand J Urol Nephrol
, vol.39
, pp. 489-497
-
-
Stegmayr, B.G.1
Brannstrom, M.2
Bucht, S.3
Crougneau, V.4
Dimeny, E.5
Ekspong, A.6
Eriksson, M.7
Granroth, B.8
Grontoft, K.C.9
Hadimeri, H.10
Holmberg, B.11
Ingman, B.12
Isaksson, B.13
Johansson, G.14
Lindberger, K.15
Lundberg, L.16
Mikaelsson, L.17
Olausson, E.18
Persson, B.19
Stenlund, H.20
Wikdahl, A.M.21
more..
-
28
-
-
0038512398
-
Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease
-
Tonelli M, Moye L, Sacks FM, Cole T, Curhan GC. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003;14:1605-1613.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1605-1613
-
-
Tonelli, M.1
Moye, L.2
Sacks, F.M.3
Cole, T.4
Curhan, G.C.5
-
29
-
-
1542287590
-
Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis?
-
Vernaglione L, Cristofano C, Muscogiuri P, Chimienti S. Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis? Am J Kidney Dis 2004;43:471-478.
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 471-478
-
-
Vernaglione, L.1
Cristofano, C.2
Muscogiuri, P.3
Chimienti, S.4
-
30
-
-
77958484945
-
Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
-
Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS. Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. Atherosclerosis 2010;213:218-224.
-
(2010)
Atherosclerosis
, vol.213
, pp. 218-224
-
-
Fassett, R.G.1
Robertson, I.K.2
Ball, M.J.3
Geraghty, D.P.4
Coombes, J.S.5
-
31
-
-
0029811045
-
A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone
-
Rayner BL, Byrne MJ, van Zyl Smit R. A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone. Clin Nephrol 1996;46: 219-224.
-
(1996)
Clin Nephrol
, vol.46
, pp. 219-224
-
-
Rayner, B.L.1
Byrne, M.J.2
Van Zyl Smit, R.3
-
32
-
-
0036180635
-
Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis
-
Saltissi D, Morgan C, Rigby RJ, Westhuyzen J. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis. Am J Kidney Dis 2002;39:283-290.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 283-290
-
-
Saltissi, D.1
Morgan, C.2
Rigby, R.J.3
Westhuyzen, J.4
-
33
-
-
0025990599
-
Free oxygen species metabolism during haemodialysis with different membranes
-
Luciak M, Trznadel K. Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant 1991;6(Suppl. 3):66-70.
-
(1991)
Nephrol Dial Transplant
, vol.6
, Issue.SUPPL. 3
, pp. 66-70
-
-
Luciak, M.1
Trznadel, K.2
-
34
-
-
27144534466
-
Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease
-
Verma A, Ranganna KM, Reddy RS, Verma M, Gordon NF. Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease. Am J Cardiol 2005;96:1290-1292.
-
(2005)
Am J Cardiol
, vol.96
, pp. 1290-1292
-
-
Verma, A.1
Ranganna, K.M.2
Reddy, R.S.3
Verma, M.4
Gordon, N.F.5
-
35
-
-
20044387406
-
First United Kingdom Heart Renal Protection (UK-HARP-I)study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
-
Baigent C, Landray M, Leaper C, Altmann P, Armitage J, Baxter A, Cairns HS, Collins R, Foley RN, Frighi V, Kourellias K, Ratcliffe PJ, Rogerson M, Scoble JE, Tomson CR, Warwick G, Wheeler DC. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. Am J Kidney Dis 2005; 45:473-484.
-
(2005)
Am J Kidney Dis
, vol.45
, pp. 473-484
-
-
Baigent, C.1
Landray, M.2
Leaper, C.3
Altmann, P.4
Armitage, J.5
Baxter, A.6
Cairns, H.S.7
Collins, R.8
Foley, R.N.9
Frighi, V.10
Kourellias, K.11
Ratcliffe, P.J.12
Rogerson, M.13
Scoble, J.E.14
Tomson, C.R.15
Warwick, G.16
Wheeler, D.C.17
-
36
-
-
6344235435
-
Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: A placebo-controlled study
-
Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA. Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study. Clin Nephrol 2004;62: 287-294.
-
(2004)
Clin Nephrol
, vol.62
, pp. 287-294
-
-
Lins, R.L.1
Matthys, K.E.2
Billiouw, J.M.3
Dratwa, M.4
Dupont, P.5
Lameire, N.H.6
Peeters, P.C.7
Stolear, J.C.8
Tielemans, C.9
Maes, B.10
Verpooten, G.A.11
Ducobu, J.12
Carpentier, Y.A.13
-
37
-
-
0037166636
-
Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey 1988-1994)
-
Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002;162:1401-1408.
-
(2002)
Arch Intern Med
, vol.162
, pp. 1401-1408
-
-
Astor, B.C.1
Muntner, P.2
Levin, A.3
Eustace, J.A.4
Coresh, J.5
-
38
-
-
0042885985
-
Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
-
London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1731-1740
-
-
London, G.M.1
Guerin, A.P.2
Marchais, S.J.3
Metivier, F.4
Pannier, B.5
Adda, H.6
-
39
-
-
3042844018
-
Association between serum homocysteine and markers of impaired kidney function in adults in the United States
-
Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 2004;66:303-312.
-
(2004)
Kidney Int
, vol.66
, pp. 303-312
-
-
Francis, M.E.1
Eggers, P.W.2
Hostetter, T.H.3
Briggs, J.P.4
-
40
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278.
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
Kirby, A.7
Sourjina, T.8
Peto, R.9
Collins, R.10
Simes, R.11
-
42
-
-
7344249596
-
Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism
-
Ribeiro S, Ramos A, Brandao A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remedio F, Ribeiro F. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13:2037-2040.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 2037-2040
-
-
Ribeiro, S.1
Ramos, A.2
Brandao, A.3
Rebelo, J.R.4
Guerra, A.5
Resina, C.6
Vila-Lobos, A.7
Carvalho, F.8
Remedio, F.9
Ribeiro, F.10
-
44
-
-
0029028148
-
Detection of oxidants in uremic plasma by electron spin resonance spectroscopy
-
Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 1995;48:199-206.
-
(1995)
Kidney Int
, vol.48
, pp. 199-206
-
-
Roselaar, S.E.1
Nazhat, N.B.2
Winyard, P.G.3
Jones, P.4
Cunningham, J.5
Blake, D.R.6
-
45
-
-
0032952901
-
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
-
Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
-
(1999)
Kidney Int
, vol.55
, pp. 1899-1911
-
-
Stenvinkel, P.1
Heimburger, O.2
Paultre, F.3
Diczfalusy, U.4
Wang, T.5
Berglund, L.6
Jogestrand, T.7
|